During the past decade, Tri-City Cardiology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tri-City Cardiology" #1 collaborator was "Milton S. Hershey Medical Center" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Tri-City Cardiology" are "Heart Failure" (2 trials), "Atherosclerosis" (1 trials), "CIED Related Infection" (1 trials), "Coronary Artery Disease" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Tri-City Cardiology" in a lesser frequency.

Most popular intervention types in "Tri-City Cardiology" are "Device" (4 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "ACUITY Spiral Left Ventricular Lead" (1 trials), "AGI-1067" (1 trials), "Arm 1 (ATP+Shock)" (1 trials), "Arm 2 (shock only)" (1 trials) and "COGNIS CRT-D" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tri-City Cardiology" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Tri-City Cardiology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Tri-City Cardiology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tri-City Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".